Literature DB >> 16804974

Overexpression of c-met in the early stage of pancreatic carcinogenesis; altered expression is not sufficient for progression from chronic pancreatitis to pancreatic cancer.

Jun Yu1, Kenoki Ohuchida, Kazuhiro Mizumoto, Nami Ishikawa, Yasuhiro Ogura, Daisuke Yamada, Takuya Egami, Hayato Fujita, Seiji Ohashi, Eishi Nagai, Masao Tanaka.   

Abstract

AIM: To investigate c-met expression during early pancreatic carcinogenesis.
METHODS: We used 46 bulk tissues and 36 micro-dissected samples, including normal pancreas, chronic pancreatitis, and pancreatic cancer, for quantitative real-time reverse transcription-polymerase chain reaction.
RESULTS: In bulk tissue analyses, pancreatic cancer tissues expressed significantly higher levels of c-met than did chronic pancreatitis and normal pancreas tissues. c-met levels did not differ between chronic pancreatitis and normal pancreas tissues. In microdissection-based analyses, c-met was expressed at higher levels in microdissected pancreatic cancer cells and pancreatitis-affected epithelial cells than in normal ductal epithelial cells (both, P < 0.01). Interestingly, pancreatitis-affected epithelial cells expressed levels of c-met similar to those of pancreatic cancer cells.
CONCLUSION: Overexpression of c-met occurs during the early stage of pancreatic carcinogenesis, and a single alteration of c-met expression is not sufficient for progression of chronic pancreatitis-affected epithelial cells to pancreatic cancer cells.

Entities:  

Mesh:

Substances:

Year:  2006        PMID: 16804974      PMCID: PMC4087937          DOI: 10.3748/wjg.v12.i24.3878

Source DB:  PubMed          Journal:  World J Gastroenterol        ISSN: 1007-9327            Impact factor:   5.742


  31 in total

1.  Single-step method of RNA isolation by acid guanidinium thiocyanate-phenol-chloroform extraction.

Authors:  P Chomczynski; N Sacchi
Journal:  Anal Biochem       Date:  1987-04       Impact factor: 3.365

Review 2.  The hepatocyte growth factor and its receptor.

Authors:  F Galimi; M F Brizzi; P M Comoglio
Journal:  Stem Cells       Date:  1993-07       Impact factor: 6.277

Review 3.  Emerging multipotent aspects of hepatocyte growth factor.

Authors:  K Matsumoto; T Nakamura
Journal:  J Biochem       Date:  1996-04       Impact factor: 3.387

4.  Analysis of K-ras oncogene mutations in chronic pancreatitis with ductal hyperplasia.

Authors:  J A Rivera; C J Rall; F Graeme-Cook; C Fernández-del Castillo; P Shu; N Lakey; R Tepper; D W Rattner; A L Warshaw; A K Rustgi
Journal:  Surgery       Date:  1997-01       Impact factor: 3.982

5.  Biosynthesis of the protein encoded by the c-met proto-oncogene.

Authors:  S Giordano; M F Di Renzo; R P Narsimhan; C S Cooper; C Rosa; P M Comoglio
Journal:  Oncogene       Date:  1989-11       Impact factor: 9.867

6.  Pancreatitis and the risk of pancreatic cancer. International Pancreatitis Study Group.

Authors:  A B Lowenfels; P Maisonneuve; G Cavallini; R W Ammann; P G Lankisch; J R Andersen; E P Dimagno; A Andrén-Sandberg; L Domellöf
Journal:  N Engl J Med       Date:  1993-05-20       Impact factor: 91.245

7.  Aberrant expression of c-met mRNA in human gastric carcinomas.

Authors:  H Kuniyasu; W Yasui; H Yokozaki; Y Kitadai; E Tahara
Journal:  Int J Cancer       Date:  1993-08-19       Impact factor: 7.396

8.  Hepatocyte growth factor and Met receptor expression in human pancreatic carcinogenesis.

Authors:  T Furukawa; W P Duguid; M Kobari; S Matsuno; M S Tsao
Journal:  Am J Pathol       Date:  1995-10       Impact factor: 4.307

Review 9.  A new molecular biology approach in morphology: basic method and application of laser microdissection.

Authors:  Tetsuhiko Tachikawa; Tarou Irié
Journal:  Med Electron Microsc       Date:  2004-06

10.  Pancreatitis is a risk factor for pancreatic cancer.

Authors:  P Bansal; A Sonnenberg
Journal:  Gastroenterology       Date:  1995-07       Impact factor: 22.682

View more
  21 in total

Review 1.  Molecular biology of pancreatic cancer.

Authors:  Miroslav Zavoral; Petra Minarikova; Filip Zavada; Cyril Salek; Marek Minarik
Journal:  World J Gastroenterol       Date:  2011-06-28       Impact factor: 5.742

Review 2.  c-Met signaling in the development of tumorigenesis and chemoresistance: potential applications in pancreatic cancer.

Authors:  Daniel Delitto; Eva Vertes-George; Steven J Hughes; Kevin E Behrns; Jose G Trevino
Journal:  World J Gastroenterol       Date:  2014-07-14       Impact factor: 5.742

Review 3.  Pancreatic cancer stroma: understanding biology leads to new therapeutic strategies.

Authors:  Agnieszka Anna Rucki; Lei Zheng
Journal:  World J Gastroenterol       Date:  2014-03-07       Impact factor: 5.742

4.  Nuclear translocation of the receptor tyrosine kinase c-MET reduces the treatment efficacies of olaparib and gemcitabine in pancreatic ductal adenocarcinoma cells.

Authors:  Yuan Gao; Mei-Kuang Chen; Yu-Yi Chu; Liuqing Yang; Dihua Yu; Yingbin Liu; Mien-Chie Hung
Journal:  Am J Cancer Res       Date:  2021-01-01       Impact factor: 6.166

5.  Dual Inhibition of Hedgehog and c-Met Pathways for Pancreatic Cancer Treatment.

Authors:  Agnieszka A Rucki; Qian Xiao; Stephen Muth; Jianlin Chen; Xu Che; Jennifer Kleponis; Rajni Sharma; Robert A Anders; Elizabeth M Jaffee; Lei Zheng
Journal:  Mol Cancer Ther       Date:  2017-09-01       Impact factor: 6.261

Review 6.  New insights into pancreatic cancer stem cells.

Authors:  Chinthalapally V Rao; Altaf Mohammed
Journal:  World J Stem Cells       Date:  2015-04-26       Impact factor: 5.326

7.  c-Met affects gemcitabine resistance during carcinogenesis in a mouse model of pancreatic cancer.

Authors:  Kozo Noguchi; Masamitsu Konno; Hidetoshi Eguchi; Koichi Kawamoto; Ryouta Mukai; Naohiro Nishida; Jun Koseki; Hiroshi Wada; Hirofumi Akita; Taroh Satoh; Shigeru Marubashi; Hiroaki Nagano; Yuichiro Doki; Masaki Mori; Hideshi Ishii
Journal:  Oncol Lett       Date:  2018-05-24       Impact factor: 2.967

8.  Upregulation and redistribution of integrin alpha6beta4 expression occurs at an early stage in pancreatic adenocarcinoma progression.

Authors:  Zobeida Cruz-Monserrate; Suimin Qiu; B Mark Evers; Kathleen L O'Connor
Journal:  Mod Pathol       Date:  2007-04-13       Impact factor: 7.842

9.  LIM only 4 is overexpressed in late stage pancreas cancer.

Authors:  Jun Yu; Kenoki Ohuchida; Kohei Nakata; Kazuhiro Mizumoto; Lin Cui; Hayato Fujita; Hiroshi Yamaguchi; Takuya Egami; Hidehisa Kitada; Masao Tanaka
Journal:  Mol Cancer       Date:  2008-12-22       Impact factor: 27.401

10.  Microenvironment elements involved in the development of pancreatic cancer tumor.

Authors:  Katarzyna Gardian; Sława Janczewska; Marek Durlik
Journal:  Gastroenterol Res Pract       Date:  2012-12-13       Impact factor: 2.260

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.